These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34727195)

  • 1. Correction to: TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development.
    Yi M; Tan Y; Wang L; Cai J; Li X; Zeng Z; Xiong W; Li G; Li X; Tan P; Xiang B
    Cell Mol Life Sci; 2021 Dec; 78(23):7915. PubMed ID: 34727195
    [No Abstract]   [Full Text] [Related]  

  • 2. TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma.
    Somerville TDD; Xu Y; Miyabayashi K; Tiriac H; Cleary CR; Maia-Silva D; Milazzo JP; Tuveson DA; Vakoc CR
    Cell Rep; 2018 Nov; 25(7):1741-1755.e7. PubMed ID: 30428345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
    Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
    Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma.
    Hegde GV; de la Cruz C; Giltnane JM; Crocker L; Venkatanarayan A; Schaefer G; Dunlap D; Hoeck JD; Piskol R; Gnad F; Modrusan Z; de Sauvage FJ; Siebel CW; Jackson EL
    Elife; 2019 May; 8():. PubMed ID: 31144617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine.
    Bilguun EO; Kaira K; Kawabata-Iwakawa R; Rokudai S; Shimizu K; Yokobori T; Oyama T; Shirabe K; Nishiyama M
    BMC Cancer; 2020 Sep; 20(1):935. PubMed ID: 32993587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OVOL2 induces mesenchymal-to-epithelial transition in fibroblasts and enhances cell-state reprogramming towards epithelial lineages.
    Watanabe K; Liu Y; Noguchi S; Murray M; Chang JC; Kishima M; Nishimura H; Hashimoto K; Minoda A; Suzuki H
    Sci Rep; 2019 Apr; 9(1):6490. PubMed ID: 31019211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
    Xie JJ; Jiang YY; Jiang Y; Li CQ; Lim MC; An O; Mayakonda A; Ding LW; Long L; Sun C; Lin LH; Chen L; Wu JY; Wu ZY; Cao Q; Fang WK; Yang W; Soukiasian H; Meltzer SJ; Yang H; Fullwood M; Xu LY; Li EM; Lin DC; Koeffler HP
    Gastroenterology; 2018 Jun; 154(8):2137-2151.e1. PubMed ID: 29454790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63.
    Zarnegar BJ; Webster DE; Lopez-Pajares V; Vander Stoep Hunt B; Qu K; Yan KJ; Berk DR; Sen GL; Khavari PA
    Am J Hum Genet; 2012 Sep; 91(3):435-43. PubMed ID: 22922031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.
    Jiang Y; Jiang YY; Xie JJ; Mayakonda A; Hazawa M; Chen L; Xiao JF; Li CQ; Huang ML; Ding LW; Sun QY; Xu L; Kanojia D; Jeitany M; Deng JW; Liao LD; Soukiasian HJ; Berman BP; Hao JJ; Xu LY; Li EM; Wang MR; Bi XG; Lin DC; Koeffler HP
    Nat Commun; 2018 Sep; 9(1):3619. PubMed ID: 30190462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed.
    Yen CC; Chen YJ; Pan CC; Lu KH; Chen PC; Hsia JY; Chen JT; Wu YC; Hsu WH; Wang LS; Huang MH; Huang BS; Hu CP; Chen PM; Lin CH
    World J Gastroenterol; 2005 Mar; 11(9):1267-72. PubMed ID: 15761962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.
    Lakshmanachetty S; Balaiya V; High WA; Koster MI
    Mol Cancer Res; 2019 Jun; 17(6):1279-1293. PubMed ID: 30910837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics, Enhancer Function and 3D Chromatin Organization in Reprogramming to Pluripotency.
    Hörnblad A; Remeseiro S
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma.
    Pallier K; Cazes A; El Khattabi L; Lecchi C; Desroches M; Danel C; Riquet M; Fabre-Guillevin E; Laurent-Puig P; Blons H
    Tumour Biol; 2012 Feb; 33(1):41-51. PubMed ID: 21986963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency.
    Liu P; Chen M; Liu Y; Qi LS; Ding S
    Cell Stem Cell; 2018 Feb; 22(2):252-261.e4. PubMed ID: 29358044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
    Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
    Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHD1L Regulated PARP1-Driven Pluripotency and Chromatin Remodeling During the Early-Stage Cell Reprogramming.
    Jiang BH; Chen WY; Li HY; Chien Y; Chang WC; Hsieh PC; Wu P; Chen CY; Song HY; Chien CS; Sung YJ; Chiou SH
    Stem Cells; 2015 Oct; 33(10):2961-72. PubMed ID: 26201266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas.
    Yang H; Schramek D; Adam RC; Keyes BE; Wang P; Zheng D; Fuchs E
    Elife; 2015 Nov; 4():e10870. PubMed ID: 26590320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.
    Chari NS; Ivan C; Le X; Li J; Mijiti A; Patel AA; Osman AA; Peterson CB; Williams MD; Pickering CR; Caulin C; Myers JN; Calin GA; Lai SY
    J Natl Cancer Inst; 2020 Mar; 112(3):266-277. PubMed ID: 31124563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research and Clinical Significance of the Differentially Expressed Genes TP63 and LMO4 in Human Immunodeficiency Virus-Related Penile Squamous Cell Carcinoma.
    Xue W; Zheng X; Hu X; Zhang Y
    Am J Mens Health; 2021; 15(2):15579883211011380. PubMed ID: 33906487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin modulators as facilitating factors in cellular reprogramming.
    Luna-Zurita L; Bruneau BG
    Curr Opin Genet Dev; 2013 Oct; 23(5):556-61. PubMed ID: 23993229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.